Clinical Cases in Pharmacology Clinical Cases  ·  Allergy and Immunology Vol. III  ·  Non-Disease-Specific Pharmacology/Therapeutics  ·  Sensitized to Five Things, Willing to Tolerate Shots for Maybe Two
Allergy and Immunology Vol. III, Case AIPharm-0012 — Non-Disease-Specific Pharmacology/Therapeutics

Sensitized to Five Things, Willing to Tolerate Shots for Maybe Two

A polysensitized management consultant who travels four days a week can realistically commit to an injection schedule that covers only two or three of his five clinically relevant sensitizations — turning allergen selection from a technical exercise into an explicit, uncomfortable prioritization question.

Abbreviations, terms, and other agents mentioned in this case sIgE — allergen-specific IgE  ·  AAAAI/ACAAI — American Academy of Allergy, Asthma and Immunology / American College of Allergy, Asthma and Immunology
Presentation

Roberto C., 34, works as a management consultant with a travel schedule that puts him in a different city four days most weeks, a pace he's sustained for six years and doesn't expect to change anytime soon. Allergic rhinitis has worsened steadily over the past three years — congestion, itchy eyes, and disrupted sleep that now spans most of the calendar rather than one clear season — and skin testing confirmed clinically significant sensitization to five allergens: dust mite, cat dander, ragweed, timothy grass, and oak pollen, with symptom diary correlation strongest for dust mite (year-round, worst) and ragweed (a sharp late-summer spike that has twice triggered asthma-like wheezing), moderate for timothy grass, and comparatively mild for cat and oak despite meaningful sIgE titers to both.

A full five-allergen immunotherapy build-up would require weekly injections for several months — a schedule Roberto says plainly he cannot sustain given his travel pattern, having already missed two consecutive appointments before this visit for exactly that reason. He has asked directly for help deciding which two or three allergens are actually worth the injection burden he can realistically commit to, rather than being handed a five-allergen extract and predictably falling off the schedule within months.

He came into today's visit somewhat apologetically, framing the request as an admission of failure rather than what it actually is — a reasonable adaptation to a real constraint. He has tried, on his own initiative, to reschedule around his travel calendar twice already and found the unpredictability of last-minute client trips made even a flexible weekly slot unreliable. What he wants out of this visit isn't permission to quit immunotherapy, which he's genuinely reluctant to do. It is a version of the treatment built around the schedule he actually has — and his own diary has already done most of the choosing for him, since the two allergens with the strongest symptom correlation are not the two with the highest titers, which means the list can be cut without the cut costing him anything he can feel.

Roberto C. · 34 Limited injection tolerance
History
Progressive allergic rhinitis, 3 years; polysensitized on skin testing
Sensitizations
Dust mite, cat dander, ragweed, timothy grass, oak pollen — all clinically significant sIgE
Symptom correlation
Strongest: dust mite (year-round) and ragweed (late-summer spike, 2x wheezing episodes); weakest: cat, oak
Travel schedule
4 days/week travel, unpredictable city-to-city; missed 2 consecutive build-up appointments
Asthma history
No formal diagnosis; wheezing episodes correlate specifically with ragweed season
Prior therapy
Intranasal corticosteroid and second-generation antihistamine, both maximized, incomplete benefit

Choosing which allergens actually earn a seat

Allergist/Immunologist Opening

I'd prioritize by symptom correlation, not by titer. His sIgE to cat and oak are both meaningful, but his own diary shows they barely register symptomatically, while dust mite and ragweed are clearly driving his worst weeks — ragweed severely enough to produce wheezing twice. The AAAAI/ACAAI practice parameter is explicit that allergen selection for immunotherapy should be guided by clinical relevance, not sensitization magnitude alone. Dust mite and ragweed would be my two, with timothy grass a reasonable third if his schedule genuinely allows it.

Clinical Pharmacologist Response

Before we cut allergens, I'd want to separate two different constraints that are getting collapsed into one. Roberto's actual problem, as he's described it, is visit frequency during an unpredictable travel schedule — not literally how many allergens are in the vial. Cluster immunotherapy protocols compress the build-up phase into fewer total visits, sometimes several escalating doses per visit rather than one dose per week, without changing how many allergens are included. If the real bottleneck is his calendar rather than his tolerance for multiple allergens, a cluster schedule might let him keep three or even more allergens without the missed-appointment pattern he's already shown.

I don't disagree with the allergist's prioritization logic if we do end up needing to cut — I'm just not convinced yet that we do, and I'd want the scheduling fix tried before we assume allergen count itself is the problem.

Nurse Coordinator Final

I'll add what I actually see run the injection clinic day to day: even with cluster scheduling, patients under real, ongoing time pressure who try to carry three or more allergens disproportionately end up missing doses or plateauing below full maintenance concentration on at least one of them — and a partially-dosed allergen contributes less benefit than the same allergen fully maintained, sometimes close to none. Given Roberto's own admission that he's already missed two appointments trying to manage this alongside his existing schedule, I'd lean toward two allergens reliably taken to full maintenance over three or four carried at a compromise pace that risks under-dosing all of them.

Regimen selected
Dust Mite + Ragweed Extract (Cluster Protocol)
Subcutaneous Allergen Immunotherapy · Compressed build-up schedule
Selected as the two highest-relevance allergens per symptom correlation; cluster dosing attempted first to test whether his schedule tolerates full maintenance on both before adding a third.
Timothy Grass — Deferred
Subcutaneous Allergen Immunotherapy
Not started initially; reserved as a candidate third allergen only if dust mite and ragweed reach full maintenance reliably on the cluster schedule.
Cat Dander/Oak Pollen — Excluded From Immunotherapy
Subcutaneous Allergen Immunotherapy, Not Selected
Excluded from the injection panel despite meaningful sIgE titers; symptom diary correlation was weak enough that the practice parameter's clinical-relevance criterion did not support inclusion given limited injection capacity.
Intranasal Corticosteroid — Continued
Topical Corticosteroid
Continued alongside immunotherapy for symptomatic control during the build-up phase and for any residual symptoms from allergens not covered.
Where this was left

Agreed: start dust mite and ragweed on a cluster build-up protocol designed to minimize total visit count, explicitly deferring cat dander, oak pollen, and (for now) timothy grass rather than attempting all five at a pace the coordinator's own experience predicted he would not sustain.

Roberto accepted the two-allergen start reluctantly, having hoped to address everything at once, and asked to revisit timothy grass in six months once the cluster schedule's actual feasibility against his travel pattern was proven rather than assumed. Not resolved: whether cat dander and oak, excluded primarily on symptom-correlation grounds, might become more relevant if his exposure pattern changes — the allergist noted this as worth re-checking periodically rather than treated as a permanent exclusion.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →